- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01815541
Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study (TEICOPLANIN)
August 1, 2016 updated by: Centre Hospitalier Universitaire, Amiens
This is a biomedical research, prospective, mono centric, tolerance study Of the administration of subcutaneous teicoplanin in the treatment of osteoarticular infections.
Study Overview
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Picardie
-
Amiens, Picardie, France, 80054
- CHU Amiens
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient over 18 years
- Inpatient orthopedic surgery
- Achieved a bone and joint infection documented gram + (staphylococci golden coagulase-negative staphylococci, enterococci, streptococci)
- Bacteria resistant to lincosamides, quinolones and rifampicin
- Bacteria susceptible to teicoplanin (MIC ≤ 4 mg / L)
- Balanced patient teicoplanin administered intravenously (2 successive doses between 30 and 40 mg / mL)
Exclusion Criteria:
- Patient not affiliated to the social security
- Pregnant and lactating women
- Known hypersensitivity to teicoplanin (rash, ...)
- Patients with a central catheter or an implantable chamber
- Patient hemodialysis
- Patient has another participant biomedical research on a drug to prevent drug interactions
- Patient minor
- Patient major protected (protection of the court, wardship, trusteeship)
- Patient admitted for emergency or incapable of consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: teicoplanin
this group receive the teicoplanin
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
measure of tolerance
Time Frame: 6 weeks
|
The frequencies of adverse reactions at the injection site SC will be measured to assess the local tolerance of teicoplanin by SC.
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Youssef El SAMAD, PH, CHU Amiens, France
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
March 15, 2013
First Submitted That Met QC Criteria
March 19, 2013
First Posted (Estimate)
March 21, 2013
Study Record Updates
Last Update Posted (Estimate)
August 3, 2016
Last Update Submitted That Met QC Criteria
August 1, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI2012_843_0008
- 2012-003690-25 (EudraCT Number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarticular Infection
-
Rennes University HospitalCompletedOsteoarticular InfectionFrance
-
Assistance Publique - Hôpitaux de ParisCompletedOsteoarticular InfectionFrance
-
Centre Hospitalier Universitaire de NiceRecruitingOsteoarticular InfectionFrance
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
-
Assistance Publique - Hôpitaux de ParisCompletedBone and Osteoarticular Infection Due to MDR M. Tuberculosis StrainsFrance
-
University Hospital, MontpellierCompleted
-
Ahmad Jabir RahyussalimUnknownMesenchymal Stem Cell | Spinal TuberculosisIndonesia
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of Cape TownUniversity of ZurichRecruitingInfections | Musculoskeletal Diseases | Mycobacterium Infections | Tuberculosis | Spondylitis | Bone Diseases, Infectious | Diagnostic Imaging | Positron-Emission Tomography | Spondylodiscitis | Spinal Disease | Tuberculosis, Spinal | Tuberculosis, Osteoarticular | Diagnostic Techniques and Procedures | Spondylitis...South Africa
-
Beijing Chest HospitalBeijing Municipal Science & Technology CommissionUnknownTuberculosis, SpinalChina
Clinical Trials on teicoplanin
-
SanofiTerminatedClostridium Difficile Infection-associated Diarrhea and ColitisChina
-
National Taiwan University HospitalUnknownStaphylococcal InfectionsTaiwan
-
Shandong UniversityShandong Provincial Hospital; Qianfoshan Hospital; Jinan Central Hospital; The... and other collaboratorsRecruiting
-
Children's Cancer and Leukaemia GroupUnknownInfectionUnited Kingdom, Ireland
-
Jiangsu Famous Medical Technology Co., Ltd.UnknownInfectious Disease
-
Aziende Chimiche Riunite Angelini Francesco S.p.AHippocrates ResearchCompletedAcute Bacterial Skin and Skin Structure InfectionGreece, Italy
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruiting
-
Medical University of ViennaRecruitingChronic Skin UlcerAustria
-
Neupharma SrlSintesi Research Srl; Pari Pharma GmbH; AptuitCompleted
-
Bezmialem Vakif UniversityUnknownLumbar Disc Herniation | Lumbar Spinal Stenosis | Lumbar Spondylolisthesis | Scoliosis Lumbar Region | Lumbar Disc Lesion